Jennifer R. Ribeiro

759 total citations
42 papers, 482 citations indexed

About

Jennifer R. Ribeiro is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Jennifer R. Ribeiro has authored 42 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Cancer Research and 12 papers in Immunology. Recurrent topics in Jennifer R. Ribeiro's work include Ovarian cancer diagnosis and treatment (10 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immune Cell Function and Interaction (5 papers). Jennifer R. Ribeiro is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immune Cell Function and Interaction (5 papers). Jennifer R. Ribeiro collaborates with scholars based in United States, Austria and Canada. Jennifer R. Ribeiro's co-authors include Nicole E. James, Richard N. Freiman, Richard G. Moore, Naohiro Yano, Clinton O. Chichester, Paul DiSilvestro, Rakesh K. Singh, Kyu Kwang Kim, Christoph Schorl and Ajay Singh and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jennifer R. Ribeiro

38 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer R. Ribeiro United States 13 190 158 146 132 83 42 482
Naoki Ogane Japan 14 205 1.1× 116 0.7× 160 1.1× 104 0.8× 24 0.3× 26 437
Elisabeth Smolle Austria 12 329 1.7× 146 0.9× 237 1.6× 67 0.5× 47 0.6× 21 639
Tomoko Kashiyama Japan 14 284 1.5× 121 0.8× 101 0.7× 92 0.7× 53 0.6× 23 508
Arpita Desai United States 10 229 1.2× 165 1.0× 116 0.8× 62 0.5× 31 0.4× 38 451
Yanfeng Liu China 11 242 1.3× 163 1.0× 115 0.8× 53 0.4× 56 0.7× 41 486
Seog-Nyeon Bae South Korea 8 155 0.8× 151 1.0× 116 0.8× 58 0.4× 26 0.3× 10 499
Séverine Cunat France 10 171 0.9× 138 0.9× 98 0.7× 101 0.8× 33 0.4× 24 527
Lihong Yin United States 11 259 1.4× 126 0.8× 81 0.6× 52 0.4× 24 0.3× 17 405
Shinji Oie Japan 12 315 1.7× 140 0.9× 88 0.6× 26 0.2× 44 0.5× 22 515

Countries citing papers authored by Jennifer R. Ribeiro

Since Specialization
Citations

This map shows the geographic impact of Jennifer R. Ribeiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer R. Ribeiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer R. Ribeiro more than expected).

Fields of papers citing papers by Jennifer R. Ribeiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer R. Ribeiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer R. Ribeiro. The network helps show where Jennifer R. Ribeiro may publish in the future.

Co-authorship network of co-authors of Jennifer R. Ribeiro

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer R. Ribeiro. A scholar is included among the top collaborators of Jennifer R. Ribeiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer R. Ribeiro. Jennifer R. Ribeiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sledge, George W., Takayuki Yoshino, Jennifer R. Ribeiro, et al.. (2025). Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals. Nature Communications. 16(1). 2646–2646. 4 indexed citations
2.
McKay, Rana R., Shayan Nazari, Andrew Elliott, et al.. (2025). Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancer. The Oncologist. 30(11).
3.
Ribeiro, Jennifer R., Todd Maney, Stephanie Rock, et al.. (2025). GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling. Cancer Research Communications. 5(9). 1477–1489. 1 indexed citations
4.
Sledge, George W., Joanne Xiu, Jeffrey P. Solzak, et al.. (2025). Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis. Breast Cancer Research. 27(1). 144–144.
5.
Cheng, Yating, Ming Chen, Joanne Xiu, et al.. (2025). Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer. Communications Medicine. 5(1). 328–328.
6.
Fernandez, Aileen I., Andrew Elliott, Maryam B. Lustberg, et al.. (2024). NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer. Breast Cancer Research. 26(1). 175–175. 4 indexed citations
7.
Trabolsi, Asaad, Estelamari Rodríguez, Jennifer R. Ribeiro, et al.. (2024). Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors. The Oncologist. 29(11). e1480–e1491. 7 indexed citations
8.
Chen, Ming, Yating Cheng, Joanne Xiu, et al.. (2024). A digital pathology AI model to predict immune-oncology biomarker status and pembrolizumab response in a real-world cohort of patients with colorectal and breast cancer.. Journal of Clinical Oncology. 42(16_suppl). e13617–e13617. 1 indexed citations
9.
Jayachandran, Priya, Sachin Kumar Deshmukh, Sharon Wu, et al.. (2024). Molecular and immunological characterization of androgen receptor expression in different breast cancer subtypes.. Journal of Clinical Oncology. 42(16_suppl). 1114–1114. 1 indexed citations
10.
Cavalcante, Ludimila, Sachin Kumar Deshmukh, Jennifer R. Ribeiro, et al.. (2023). Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers. JCO Precision Oncology. 7(7). e2300088–e2300088. 4 indexed citations
11.
Ribeiro, Jennifer R., et al.. (2023). Multiplex serum immune profiling reveals circulating LAG-3 is associated with improved patient survival in high grade serous ovarian cancer. Gynecologic Oncology. 174. 200–207. 2 indexed citations
12.
Baca, Yasmine, Jennifer R. Ribeiro, Phillip Walker, et al.. (2023). Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. JCO Precision Oncology. 7 indexed citations
13.
14.
15.
Rowswell-Turner, Rachael B., Rakesh K. Singh, Naohiro Yano, et al.. (2021). HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression. The Journal of Immunology. 206(10). 2478–2488. 19 indexed citations
16.
James, Nicole E., Jennifer R. Ribeiro, Evelyn Cantillo, et al.. (2019). Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6. Frontiers in Pharmacology. 10. 216–216. 8 indexed citations
17.
James, Nicole E., Clinton O. Chichester, & Jennifer R. Ribeiro. (2018). Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer. Frontiers in Oncology. 8. 124–124. 33 indexed citations
18.
Ribeiro, Jennifer R., Mehreen Ali Khan, Christoph Schorl, et al.. (2018). Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix. Frontiers in Oncology. 7. 332–332. 19 indexed citations
19.
Romano, N., Alex Han, Jennifer R. Ribeiro, et al.. (2015). Determination of HE4-mediated roles in tumor immune system modulation in epithelial ovarian cancer (EOC). Gynecologic Oncology. 137. 174–174. 1 indexed citations
20.
Kim, Kyu Kwang, Naohiro Yano, Jennifer R. Ribeiro, et al.. (2015). Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells. Scientific Reports. 5(1). 14296–14296. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoki Ogane Breakdown of academic impact, for papers by Elisabeth Smolle Breakdown of academic impact, for papers by Tomoko Kashiyama Breakdown of academic impact, for papers by Arpita Desai Breakdown of academic impact, for papers by Yanfeng Liu Breakdown of academic impact, for papers by Seog-Nyeon Bae Breakdown of academic impact, for papers by Séverine Cunat Breakdown of academic impact, for papers by Lihong Yin Breakdown of academic impact, for papers by Shinji Oie
Rankless by CCL
2026